Đang chuẩn bị liên kết để tải về tài liệu:
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 13)

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Macrolides and Ketolides Erythromycin, clarithromycin, and telithromycin inhibit CYP3A4, the hepatic P450 enzyme that metabolizes many drugs, including cyclosporine, certain statins (lovastatin, simvastatin), theophylline, carbamazepine, warfarin, certain antineoplastic agents (e.g., vincristine, irinotecan), and ergot alkaloids. In ~10% of patients receiving digoxin, concentrations increase significantly when erythromycin or telithromycin is coadministered, and this increase may lead to digoxin toxicity. Azithromycin has little effect on the metabolism of other drugs. Many drugs (e.g., azole antifungal drugs, diltiazem, verapamil, and nefazodone) can also increase absorption or inhibit erythromycin metabolism. .

TÀI LIỆU LIÊN QUAN

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 1)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 2)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 3)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 4)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 5)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 6)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 7)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 8)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 9)

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 10)

Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.